AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca wainua (eplontersen) — Worldwide product sales ($M) ($M)
Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables
Latest, FY2025
212
Period ended Dec 31, 2025
Change on a year earlier
+149.4%
85 in FY2024
History
2 years
Since FY2024
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Wainua (eplontersen) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 212 | +149.4% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 85 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
Breakdown
What makes up wainua (eplontersen) — worldwide product sales ($m)
- Wainua (eplontersen) — Worldwide YoY actual (%)–
- Wainua (eplontersen) — Worldwide YoY CER (%)–
- Wainua (eplontersen) — US product sales ($M)204 · FY2025
- Wainua (eplontersen) — Emerging Markets product sales ($M)4 · FY2025
- Wainua (eplontersen) — Europe product sales ($M)4 · FY2025
- Wainua (eplontersen) — Established RoW product sales ($M)0 · FY2025
Cite this data
StockData. (2026). AstraZeneca Wainua (eplontersen) — Worldwide product sales ($M) ($M), annual FY2024–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_wainua_world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.